Katarzyna is a Market Access Director for Region East at Lundbeck. In the past, she worked for AstraZeneca, Bristol Myers Squibb as well as BiogenIdec leading Market Access teams in CEE Region. In total, she has been working for pharmaceutical industry for more than ten years now. The last six years she devoted mainly to Market Access for CEE Region. Her office is located in Finland. In the past she was based in Sweden and Switzerland. She holds a PhD degree in health economics and is an author of the number of publications in the field of health technology assessment and pharmacoeconomics. Katarzyna Kolasa has been invited to review manuscripts for Health Policy, Value in Health, Expert Review of Pharmacoeconomics & Outcomes Research and International Journal for Equity in Health. Her extensive knowledge in the field of health economics was acquired at University of York, University of Lund and University of Bergen as well as during International Doctoral Courses in Health Economics and Policy organized by the Swiss School of Public Health. Katarzyna Kolasa is DIA tutor for HTA courses, teacher at MBA in health program at Lazarski University, HTA training at Business School of Technical University in Warsaw and Adjunct at Nicolaus Copernicus University Collegium Medicum in Bydgoszcz. In addition to her role as a University teacher, she lead Equity study as a part of InterQuality project organized by Warsaw Medical University, funded under the European Union\'s Seventh Framework Programme. She worked for World Bank regarding the hospital management project as well. Her practical skills in the field of health economics were developed during her six years employment contract at the Kalmar County Council in Sweden where she was responsible for a number of public health research programmes.